33，Cluff LE,et al.Studies on the epidemiology of adverse drug reactions, part 1:methodsof surveillance. JAMA,1964,188:976 被引量：1
44，Borda IT, et al.Assessment of adverse reactions within a drug surveillance program.JAMA, 1968,205:99 被引量：1
55，Miller Rr. Hospital admissions due to adverse drug reactions: a report from the BostonCollaborative Drug Surveillance Program. Arch Inter Med, 1974,134:219 被引量：1
66，Smith JW, et al. Studies on the epidemiology of adverse drug reactions. V:clinicalfactors influencing susceptibility. Ann Intern Med, 1966,65:629 被引量：1
77，Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalizedpatients: a meta-analysis of prospective studies. JAMA, 1998,279:1200-5 被引量：1
88，Kahn L, et al. The effects of the DRG-based prospective payment system on quality ofcare for hospitalized medicare patients. JAMA, 1990,264:1953 被引量：1
99，Classen DC, et al. Adverse drug events in hospitalized patients: excess length ofstay, extra costs, and attributable mortality. JAMA, 1997,227:301 被引量：1
1010，Bates DW, et al. The costs of adverse drug events in hospitalized patients. JAMA,1997,277:307 被引量：1
6Zhao HX, Wang LP, Qiu YM, et al. Multiwalled carbon nanotubes as a solid - phase extraction adsorbent for the deter ruination of three barbiturates in pork by ion trap gas chromatography - tandem mass spectrometry(GC/MS/MS) following microwave assisted derivatization[J]. Analytica Chimica Acta, 2007,586 ( 1 - 2) : 399 - 406. 被引量：1
7Kanju SA, Koichi U. Deter mination of amobarhital and phenobarbital in serum by gas chromatography - mass spectrometry with addition of formic acid to the solvent[J]. J Chromatogra B,2008, 869( 1-2):9-15. 被引量：1
8Lawrence P,Scott W. Bioanalytic considerations for pharmacokinetic and biopharmaceutic studies[J]. Clin Pharmacol, 1986,26: 332 - 335. 被引量：1
